End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14 TWD | +0.36% | +0.72% | -59.60% |
Apr. 18 | UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 634M 19.64M | Sales 2023 | 649M 20.1M | Capitalization | 4.1B 127M |
---|---|---|---|---|---|
Net income 2022 | 47M 1.46M | Net income 2023 | - 0 | EV / Sales 2022 | 8.97 x |
Net Debt 2022 | 119M 3.69M | Net Debt 2023 | 160M 4.96M | EV / Sales 2023 | 6.56 x |
P/E ratio 2022 |
116
x | P/E ratio 2023 |
5,009
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 27.77% |
1 day | +0.36% | ||
1 week | +0.72% | ||
Current month | -1.06% | ||
1 month | -51.72% | ||
3 months | -57.32% | ||
6 months | -53.18% | ||
Current year | -59.60% |
Managers | Title | Age | Since |
---|---|---|---|
Chi Hsiang Chen
CEO | Chief Executive Officer | - | 18-10-02 |
Meng Han Hsu
DFI | Director of Finance/CFO | - | 16-04-10 |
Ying Yun Fan
ADM | Chief Administrative Officer | - | 15-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Hsiang Chen
CEO | Chief Executive Officer | - | 18-10-02 |
Ping-Ho Yan
BRD | Director/Board Member | - | - |
Pai Feng Wu
PRN | Corporate Officer/Principal | - | 14-07-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 14 | +0.36% | 1,658,234 |
24-05-02 | 13.95 | -1.41% | 1,197,600 |
24-04-30 | 14.15 | +3.66% | 1,170,278 |
24-04-29 | 13.65 | -1.80% | 1,319,860 |
24-04-26 | 13.9 | -12.30% | 2,051,385 |
End-of-day quote Taipei Exchange, May 02, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-59.60% | 51.25M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- 6562 Stock